ad35-grin

Vaccineexperimental

Clinical trial activity

4 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Mar 1, 2009 (NCT00851383)

Timeline

2000s

  1. Jan 1, 2009

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ad35-grin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02099994Phase 1/Phase 2 (Phase 2)Mar 1, 2014European and Developing Countries Clinical Trials Partnership (EDCTP), Ichor Medical Systems Incorporated, International AIDS Vaccine Initiative, Karolinska Institute, University of Nairobi, University of Oxford
NCT01705990Phase 1Mar 1, 2013International AIDS Vaccine Initiative
NCT01264445Phase 1Feb 1, 2011GlaxoSmithKline, International AIDS Vaccine Initiative, Kenya AIDS Vaccine Initiative, Medical Research Council-UVRI Uganda Research Unit on AIDS, Uganda Virus Research Institute, Zambia-Emory HIV Research Project
NCT00851383Phase 1Mar 1, 2009International AIDS Vaccine Initiative, University of Rochester
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
International AIDS Vaccine InitiativeAcademic/Hospital4322009
European and Developing Countries Clinical Trials Partnership (EDCTP)Academic/Hospital1012014
GlaxoSmithKlineFor profit1012011
Ichor Medical Systems IncorporatedFor profit1012014
Karolinska InstituteAcademic/Hospital1012014
Kenya AIDS Vaccine InitiativeAcademic/Hospital1012011
Medical Research Council-UVRI Uganda Research Unit on AIDSAcademic/Hospital1012011
Uganda Virus Research InstituteAcademic/Hospital1012011
University of NairobiAcademic/Hospital1012014
University of OxfordAcademic/Hospital1112014
University of RochesterAcademic/Hospital1012009
Zambia-Emory HIV Research ProjectAcademic/Hospital1012011
12 organizations
Page 1 / 1